Skip to content

Biomarker for malignant pleural mesothelioma

Biomarker for malignant pleural mesothelioma - Biomarker for malignant pleural mesothelioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049240
Enrollment
45
Registered
2022-10-20
Start date
2022-08-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignat pleural mesothelioma

Interventions

None listed

Sponsors

Tokyo Womens Medical University, Tokyo, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with malignant pleural mesothelioma over 18 years old

Exclusion criteria

Exclusion criteria: patients under 17 years old

Design outcomes

Primary

MeasureTime frame
Overall survival

Countries

Japan,North America

Contacts

Public ContactKen Arimura

Tokyo Womens Medical University, Tokyo, Japan Department of Respiratory Medicine

arimuraken@gmail.com0333538111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026